Cargando…
Mutated Isocitrate Dehydrogenase (mIDH) as Target for PET Imaging in Gliomas
Gliomas are the most common primary brain tumors in adults. A diffuse infiltrative growth pattern and high resistance to therapy make them largely incurable, but there are significant differences in the prognosis of patients with different subtypes of glioma. Mutations in isocitrate dehydrogenase (I...
Autores principales: | Neumaier, Felix, Zlatopolskiy, Boris D., Neumaier, Bernd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10096429/ https://www.ncbi.nlm.nih.gov/pubmed/37049661 http://dx.doi.org/10.3390/molecules28072890 |
Ejemplares similares
-
Novel Radioiodinated and Radiofluorinated Analogues of FT-2102 for SPECT or PET Imaging of mIDH1 Mutant Tumours
por: Weber, Valérie, et al.
Publicado: (2022) -
Isocitrate Dehydrogenase IDH1 and IDH2 Mutations in Human Cancer: Prognostic Implications for Gliomas
por: Murugan, A. K., et al.
Publicado: (2022) -
Preparation of N(In)-Methyl-6-[(18)F]fluoro- and 5-Hydroxy-7-[(18)F]fluorotryptophans as Candidate PET-Tracers for Pathway-Specific Visualization of Tryptophan Metabolism
por: Kolks, Niklas, et al.
Publicado: (2023) -
Isocitrate dehydrogenase (IDH) status prediction in histopathology images of gliomas using deep learning
por: Liu, Sidong, et al.
Publicado: (2020) -
Nuclear Medicine in Times of COVID-19: How Radiopharmaceuticals Could Help to Fight the Current and Future Pandemics
por: Neumaier, Felix, et al.
Publicado: (2020)